Letters, Testimony & Comments

March 3, 2005
Testimony of the Biotechnology Industry Organization (BIO) before the Maryland House Health and Government Operations Committee opposing House Bill 885: The Human Cloning Prohibition Act of 2005. (March 3, 2005)
March 2, 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland Senate Education, Health and Environmental Affairs Committee Regarding Senate Bill 751 The Maryland Stem Cell Research Act of 2005 Madam Chair and members for the...
March 2, 2005
Testimony of the Biotechnology Industry Organization (BIO) before the Maryland Senate Education, Health and Environmental Affairs Committee in support of Senate Bill 751: The Maryland Stem Cell Research Act of 2005. (March 2, 2005)
February 28, 2005
Comments by BIO; CHMP/437/04
February 23, 2005
Dr. Hambrick and members of the APC Advisory Panel, thank you for the opportunity to be here today. Unfortunately, Terry Ghio was unable to testify. My name is Beth Roberts, and I am a partner at Hogan & Hartson and serve as outside counsel to...
February 22, 2005
February 11, 2005
February 10, 2005
Testimony to oppose Hawaii Senate Bill 1036 which "provides strict liability for injuries caused by biotech products from plant sources" (February 10, 2005).
February 10, 2005
Testimony to oppose Senate Bills 1425 and 1692 which relate the regulation of bioprospecting (February 10, 2005).
February 10, 2005
Testimony to oppose Senate Bills 644, 645, 647, 649, 1037, 1847 which propose to restrict or ban or otherwise regulate various aspects of agricultural biotechnology (February 10, 2005).
February 9, 2005
to place liability on manufacturers for "claims and damages resulting from the use, according to the label and directions for use, of genetically engineered seeds and plant parts." (February 9, 2005).
January 31, 2005
Supporting House Bill 1268, which would preserve therapeutic cloning research in the state
January 31, 2005
Supporting House Bill 1268, which would preserve therapeutic cloning research in the state (January 31, 2005).
January 9, 2005
BIO's comments on the Proposed Bulletin for Good Guidance Practices released by the Office of Management and Budget (OMB).
January 9, 2005
BIO's comments on the Centers for Medicare and Medicaid Servicesí final rule regarding revisions to the hospital outpatient prospective payment system (OPPS).
January 5, 2005
Docket No. 2004D-0440, Federal Register: October 4th, 2004 (Volume 69, Pages 59239-59240).